APA (7th ed.) Citation

Furlanetto, J., Jackisch, C., Untch, M., Schneeweiss, A., Schmatloch, S., Aktaş, B., . . . Minckwitz, G. v. (2017). Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer: Results from the neoadjuvant randomized GeparSepto study (GBG 69). Breast cancer research and treatment, 163(3), . https://doi.org/10.1007/s10549-017-4200-1

Chicago Style (17th ed.) Citation

Furlanetto, Jenny, et al. "Efficacy and Safety of Nab-paclitaxel 125 Mg/m2 and Nab-paclitaxel 150 Mg/m2 Compared to Paclitaxel in Early High-risk Breast Cancer: Results from the Neoadjuvant Randomized GeparSepto Study (GBG 69)." Breast Cancer Research and Treatment 163, no. 3 (2017). https://doi.org/10.1007/s10549-017-4200-1.

MLA (9th ed.) Citation

Furlanetto, Jenny, et al. "Efficacy and Safety of Nab-paclitaxel 125 Mg/m2 and Nab-paclitaxel 150 Mg/m2 Compared to Paclitaxel in Early High-risk Breast Cancer: Results from the Neoadjuvant Randomized GeparSepto Study (GBG 69)." Breast Cancer Research and Treatment, vol. 163, no. 3, 2017, https://doi.org/10.1007/s10549-017-4200-1.